Clinical Trial Update: Vorinostat (SAHA) in Uterine Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial testing vorinostat (SAHA) in uterine sarcoma was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcomas Uterine
• Endometrial Stromal Tumors
• Leiomyosarcoma

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Medical University of Graz | Conditions: Leiomyosarcoma, Endometrial Stromal Tumors | Phase 2 | Status: TERMINATED | Results posted: 2020-07-27